SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Senores Pharmaceuticals informs about earnings conference call

19 Jul 2025 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Senores Pharmaceuticals has informed that, post announcement of Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025, the Company will hold the earnings conference call for Q1FY26 on Thursday, July 24, 2025, at 03:30 PM (IST). The details of the aforesaid earnings conference call are annexed. The audio recording and transcript of the aforesaid call will be subsequently published on the website of the Company and will be intimated accordingly. 

The above information is a part of company’s filings submitted to BSE. 

Senores Pharmaceutic Share Price

966.55 34.10 (3.66%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×